Current status of lung transplantation

European Respiratory Journal, Supplement

Volumn 22, Issue 47, 2003, Pages

  Lau, C L ^a   Patterson, G A ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Queeny Tower ^*  (United States)

Author keywords

Bronchiolitis obliterans syndrome; Donor selection; Lung transplantation; Reperfusion injury

Indexed keywords

ALPHA 1 ANTITRYPSIN; AMPHOTERICIN; AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN A; CYTOCHROME P450; EVEROLIMUS; FLUCONAZOLE; GANCICLOVIR; LEFLUNOMIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NAFCILLIN; NITRIC OXIDE; OXYGEN; PHENYTOIN; PROSTACYCLIN; RAPAMYCIN; RIFAMPICIN; TACROLIMUS; VALGANCICLOVIR;

ALLOGRAFT; BRAIN DEATH; BRONCHIOLITIS; BRONCHOSCOPY; CONFERENCE PAPER; CYSTIC FIBROSIS; DEBRIDEMENT; DONOR; EMPHYSEMA; EXTRACORPOREAL OXYGENATION; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; GRAFT REJECTION; HUMAN; IMMUNOLOGICAL TOLERANCE; INFECTION; LUNG DISEASE; LUNG EDEMA; LUNG FIBROSIS; LUNG GAS EXCHANGE; LUNG TRANSPLANTATION; MORTALITY; OXYGEN THERAPY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QUALITY OF LIFE; REPERFUSION INJURY; RESPIRATORY TRACT DISEASE; RISK FACTOR; SURVIVAL; THORAX RADIOGRAPHY; BRONCHIOLITIS OBLITERANS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; FEMALE; FORECASTING; GRAFT SURVIVAL; HISTOCOMPATIBILITY; MALE; PATHOLOGY; POSTOPERATIVE COMPLICATION; PROGNOSIS; REVIEW; RISK ASSESSMENT; STANDARD; UNITED STATES;

BRONCHIOLITIS OBLITERANS; FEMALE; FORECASTING; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; LUNG DISEASES; LUNG TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY FIBROSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS; TISSUE DONORS; TRANSPLANTATION IMMUNOLOGY; UNITED STATES;

EID: 0242322678     PISSN: 09041850     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (96)

1. Toronto Lung Transplantation Group. Unilateral lung transplantation for pulmonary fibrosis. N Engl J Med 1986; 314: 1140-1145.
2. Hertz MI, Taylor DO, Trulock EP, et al. The Registry of the International Society for Heart and Lung Transplantation: nineteenth official report - 2002. J Heart Lung Transplant 2002; 21: 950-970.
3. Meyers BF, Lynch J, Trulock EP, Guthrie TJ, Cooper JD, Patterson GA. Lung transplantation: a decade of experience. Ann Surg 1999; 230: 362-370 (discussion 370-371).
4. Ramsey SD, Patrick DL, Lewis S, Albert RK, Raghu G. Improvement in quality of life after lung transplantation: a preliminary study. The University of Washington Medical Center Lung Transplant Study Group. J Heart Lung Transplant 1995; 14: 870-877.
5. Cohen L, Littlefield C, Kelly P, Maurer J, Abbey S. Predictors of quality of life and adjustment after lung transplantation. Chest 1998; 113: 633-644.
6. Limbos MM, Chan CK, Kesten S. Quality of life in female lung transplant candidates and recipients. Chest 1997; 112: 1165-1174.
7. Limbos MM, Joyce DP, Chan CK, Kesten S. Psychological functioning and quality of life in lung transplant candidates and recipients. Chest 2000; 118: 408-416.
8. Gross CR, Raghu G. The cost of lung transplantation and the quality of life post-transplant. Clin Chest Med 1997; 18: 391-403.
9. TenVergert EM, Essink-Bot M-L, Geertsma A, van Enckevort PJ, de Boer WJ, van der Bij W. The effect of lung transplantation on health-related quality of life: a longitudinal study. Chest 1998; 113: 358-364.
10. TenVergert EM, Vermeulen KM, Geertsma A, et al. Quality of life before and after lung transplantation in patients with emphysema versus other indications. Psychol Rep 2001; 89: 707-717.
11. Egan TM, Bennett LE, Garrity ER, et al. Predictors of death on the UNOS lung transplant waiting list: results of a multivariate analysis. J Heart Lung Transplant 2001; 20: 242A.
12. De Meester J, Smits JM, Persijn GG, Haverich A. Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J Heart Lung Transplant 2001; 20: 518-524.
13. Hosenpud JD, Bennett LE, Keck BM, Edwards EB, Novick RJ. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998; 351: 24-27.
14. Charman SC, Sharples LD, McNeil KD, Wallwork J. Assessment of survival benefit after lung transplantation by patient diagnosis. J Heart Lung Transplant 2002; 21: 226-232.
15. Trulock EP. Lung transplantation. Am J Respir Crit Care Med 1997; 155: 789-818.
16. McLaughlin VV, Genthner DE, Panella MM, Rich S. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med 1998; 338: 273-277.
17. National Health Service. Cardiothoracic organ sharing principles. http://www.uktransplant.org.uk/about_transplants/organ_allocation/ cardiothoracic/cardiothoracic_organ_sharing_principles/ cardiothoracic_organ_sharing_principles.htm Date updated: 19 July 2003.
18. Huddleston CB, Bloch JB, Sweet SC, de la Morena M, Patterson GA, Mendeloff EN. Lung transplantation in children. Ann Surg 2002; 236: 270-276.
19. Huddleston CB, Mendeloff EN. Lung transplantation in infants. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2001; 4: 115-122.
20. Sundaresan S, Trachiotis GD, Aoe M, Patterson GA, Cooper JD. Donor lung procurement: assessment and operative technique. Ann Thorac Surg 1993; 56: 1409-1413.
21. Straznicka M, Follette DM, Eisner MD, Roberts PF, Menza RL, Babcock WD. Aggressive management of lung donors classified as unacceptable: excellent recipient survival one year after transplantation. J Thorac Cardiovasc Surg 2002; 124: 250-258.
22. Weill D, Dey GC, Hicks RA, et al. A positive donor Gram stain does not predict outcome following lung transplantation. J Heart Lung Transplant 2002; 21: 555-558.
23. Sundaresan S, Semenkovich J, Ochoa L, et al. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg 1995; 109: 1075-1080.
24. Cohen RG, Barr ML, Schenkel FA, DeMeester TR, Wells WJ, Starnes VA. Living-related donor lobectomy for bilateral lobar transplantation in patients with cystic fibrosis. Ann Thorac Surg 1994; 57: 1423-1428.
25. Starnes VA, Woo MS, MacLaughlin EF, et al. Comparison of outcomes between living donor and cadaveric lung transplantation in children. Ann Thorac Surg 1999; 68: 2279-2283 (discussion 2283-2284).
26. Battafarano RJ, Anderson RC, Meyers BF, et al. Perioperative complications after living donor lobectomy. J Thorac Cardiovasc Surg 2000; 120: 909-915.
27. Couetil JA, Tolan MJ, Loulmet DF, et al. Pulmonary bipartitioning and lobar transplantation: a new approach to donor organ shortage. J Thorac Cardiovasc Surg 1997; 113: 529-537.
28. Steen S, Sjoberg T, Pierre L, Liao Q, Eriksson L, Algotsson L. Transplantation of lungs from a non-heart-beating donor. Lancet 2001; 357: 825-829.
29. Gaca JG, Lesher A, Aksoy O, et al. Disseminated intravascular coagulation in association with pig-to-primate pulmonary xenotransplantation. Transplantation 2002; 73: 1717-1723.
30. Meyers BF, Lynch JP, Trulock EP, Guthrie T, Cooper JD, Patterson GA. Single versus bilateral lung transplantation for idiopathic pulmonary fibrosis: a ten-year institutional experience. J Thorac Cardiovasc Surg 2000; 120: 99-107.
31. Cooper JD, Pearson FG, Patterson GA, et al. Technique of successful lung transplantation in humans. J Thorac Cardiovasc Surg 1987; 93: 173-181.
32. Pasque MK, Trulock EP, Cooper JD, et al. Single lung transplantation for pulmonary hypertension: single institution experience in 34 patients. Circulation 1995; 92: 2252-2258.
33. Davis RD, Trulock EP, Manley J, et al. Differences in early results after single lung transplantation. Ann Thorac Surg 1994; 58: 1327-1335.
34. Cassivi SD, Meyers BF, Battafarano RJ, et al. Thirteen-year experience in lung transplantation for emphysema. Ann Thorac Surg 2002; 74: 1663-1669 (discussion 1669-1670).
35. Meyers BF, Sundaresan RS, Guthrie T, Cooper JD, Patterson GA. Bilateral sequential lung transplantation without sternal division eliminates posttransplantation sternal complications. J Thorac Cardiovasc Surg 1998; 117: 358-364.
36. Kaiser LR, Pasque MK, Trulock EP, Low DE, Dresler CM, Cooper JD. Bilateral sequential lung transplantation: the procedure of choice for double-lung replacement. Ann Thorac Surg 1991; 52: 438-446.
37. Mendeloff EN, Huddleston CB, Mallory GB, et al. Pediatric and adult lung transplantation for cystic fibrosis. J Thorac Cardiovasc Surg 1997; 115: 404-414.
38. Chaparro C, Scavuzzo M, Winton T, Keshafjee S, Kesten S. Status of lung transplant recipients surviving beyond five years. J Heart Lung Transplant 1997; 16: 511-516.
39. Paris W, Diercks M, Bright J, et al. Return to work after lung transplantation. J Heart Lung Transplant 1998; 17: 430-436.
40. Novick RJ, Gehman KE, Ali IS, Lee J. Lung preservation: the importance of endothelial and alveolar type II cell integrity. Ann Thorac Surg 1996; 62: 302-314.
41. 1. Am Rev Respir Dis 1993; 148: 882-889.
42. Keshavjee S, Yamazaki F, Cardoso PF, McRitchie DI, Patterson GA, Cooper JD. A method for safe twelve-hour pulmonary preservation. J Thorac Cardiovasc Surg 1989; 98: 529-534.
43. Maccherini M, Keshavjee SH, Slutsky AS, Patterson GA, Edelson JD. The effect of low-potassium-dextran versus Euro-Collins solution for preservation of isolated type II pneumocytes. Transplantation 1991; 52: 621-626.
44. Fischer S, Matte-Martyn A, De Perrot M, et al. Low-potassium dextran preservation solution improves lung function after human lung transplantation. J Thorac Cardiovasc Surg 2001; 121: 594-596.
45. Yamashita M, Schmid RA, Ando K, Cooper JD, Patterson GA. Nitroprusside ameliorates lung allograft reperfusion injury. Ann Thorac Surg 1996; 62: 791-797.
46. Fujino S, Nagahiro I, Triantafillou AN, et al. Inhaled nitric oxide at the time of harvest improves early lung allograft function. Ann Thorac Surg 1997; 63: 1383-1390.
47. 1. J Heart Lung Transplant 1997; 16: 658-666.
48. Venuta F, Rendina EA, Bufi M, et al. Preimplantation retrograde pneumoplegia in clinical lung transplantation. J Thorac Cardiovasc Surg 1999; 118: 107-114.
49. Halldorsson A, Kronon M, Allen BS, et al. Controlled reperfusion prevents pulmonary injury after 24-hours of lung preservation. Ann Thorac Surg 1998; 66: 877-884 (discussion 884-885).
50. Halldorsson A, Kronon M, Allen BS, et al. Controlled reperfusion after lung ischemia: implications for improved function after lung transplantation. J Thorac Cardiovasc Surg 1998; 115: 415-425.
51. Clark SC, Sudarshan C, Khanna R, Roughan J, Flecknell PA. Controlled reperfusion and pentoxifylline modulates reperfusion injury after single lung transplantation. J Thorac Cardiovasc Surg 1998; 115: 1335-1341.
52. Bhabra MS, Hopkinson DN, Shaw TE, Onwu N, Hooper TL. Controlled reperfusion protects lung grafts during a transient early increase in permeability. Ann Thorac Surg 1998; 65: 187-192.
53. Halldorsson AO, Kronon MT, Allen BS, Rahman S, Wang T. Lowering reperfusion pressure reduces the injury after pulmonary ischemia. Ann Thorac Surg 2000; 69: 198-203 (discussion 204).
54. Clark SC, Sudarshan CD, Dark JH. Controlled perfusion of the transplanted lung. Ann Thorac Surg 2001; 71: 1755-1756.
55. Fiser SM, Kron IL, Long SM, et al. Controlled perfusion decreases reperfusion injury after high-flow reperfusion. J Heart Lung Transplant 2002; 21: 687-691.
56. Lick SD, Brown PS Jr, Kurusz M, Vertrees RA, McQuitty CK, Johnston WE. Technique of controlled reperfusion of the transplanted lung in humans. Ann Thorac Surg 2000; 69: 910-912.
57. Date H, Triantafillou A, Trulock E, Cooper J, Patterson G. Inhaled nitric oxide reduces human lung allograft dysfunction. J Thorac Cardiovasc Surg 1996; 111: 913-919.
58. Fiser SM, Cope JT, Kron IL, et al. Aerosolized prostacyclin (epoprostenol) as an alternative to inhaled nitric oxide for patients with reperfusion injury after lung transplantation. J Thorac Cardiovasc Surg 2001; 121: 981-982. (Erratum in J Thorac Cardiovasc Surg 2001; 121: 1136).
59. Fiser SM, Cope JT, Kron IL, et al. Aerosolized prostacyclin (epoprostenol) as an alternative to inhaled nitric oxide for patients with reperfusion injury after lung transplantation. J Thorac Cardiovasc Surg 2001; 121: 981-982. (Erratum in J Thorac Cardiovasc Surg 2001; 121: 1136).
60. Meyers BF, Sundt TM 3rd, Henry S, et al. Selective use of extracorporeal membrane oxygenation is warranted after lung transplantation. J Thorac Cardiovasc Surg 2000; 120: 20-26.
61. Date H, Trulock EP, Arcidi JM, Sundaresan S, Cooper JD, Patterson GA. Improved airway healing after lung transplantation: an analysis of 348 bronchial anastomoses. J Thorac Cardiovasc Surg 1995; 110: 1424-1433.
62. Susanto I, Peters JI, Levine SM, Sako EY, Anzueto A, Bryan CL. Use of balloon-expandable metallic stents in the management of bronchial stenosis and bronchomalacia after lung transplantation. Chest 1998; 114: 1330-1335.
63. Chhajed PJ, Malouf MM, Tamm M, Spratt P, Glanville AR. Interventional bronchoscopy for the management of airway complications following lung transplantation. Chest 2001; 120: 1894-1899.
64. Chaparro C, Kesten S. Infections in lung transplant recipients. Clin Chest Med 1997; 18: 339-351.
65. Ettinger NA, Bailey TC, Trulock EP, et al. Cytomegalovirus infection and pneumonitis. Impact after isolation lung transplantation. Am Rev Respir Dis 1993; 147: 1017-1023.
66. Gutierrez CA, Chaparro C, Drajden M, Winton T, Kesten S. Cytomegalovirus viremia in lung transplant recipients receiving ganciclovir and immune globulin. Chest 1998; 113: 924-932.
67. Kanj SS, Welty-Wolf K, Madden J, et al. Fungal infections in lung and heart-lung transplant recipients. Report of 9 cases and review of the literature. Medicine (Baltimore) 1996; 75: 142-156.
68. Husain AN, Siddiqui MT, Holmes EW, et al. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 1999; 159: 829-833.
69. Hopkins PM, Aboyoun CL, Chhajed PN, et al. Prospective analysis of 1,235 transbronchial lung biopsies in lung transplant recipients. J Heart Lung Transplant 2002; 21: 1062-1067.
70. Berry GJ, Brunt EM, Chamberlain D, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. J Heart Lung Transplant 1990; 9: 593-601.
71. Yousem SA, Berry GJ, Cagle PT, et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant 1996; 15: 1-15.
72. Sharples LD, McNeil K, Stewart S, Wallwork J. Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung Transplant 2002; 21: 271-281.
73. Trulock EP, Ettinger NA, Brunt EM, Pasque MK, Kaiser LR, Cooper JD. The role of transbronchial lung biopsy in the treatment of lung transplant recipients: an analysis of 200 consecutive procedures. Chest 1992; 102: 1049-1054.
74. Higenbottam T, Stewart S, Penketh A, Wallwork J. Transbronchial lung biopsy for the diagnosis of rejection in heart-lung transplant patients. Transplantation 1988; 46: 532-539.
75. Sibley RK. The role of transbronchial biopsies in the management of lung transplant recipients. J Heart Lung Transplant 1993; 12: 308-324.
76. Boehler A, Vogt P, Zollinger A, Weder W, Speich R. Prospective study of the value of transbronchial lung biopsy after lung transplantation. Eur Respir J 1996; 9: 658-662.
77. Guilinger RA, Paradis IL, Dauber JH, et al. The importance of bronchoscopy with transbronchial biopsy and bronchoalveolar lavage in the management of lung transplant recipients. Am J Respir Crit Care Med 1995; 152: 2037-2043.
78. Baz MA, Layish DT, Govert JA, et al. Diagnostic yield of bronchoscopies after isolated lung transplantation. Chest 1996; 110: 84-88.
79. Tamm M, Sharples LD, Higenbottam TW, Stewart S, Wallwork J. Bronchiolitis obliterans syndrome in heart-lung transplantation: surveillance biopsies. Am J Respir Crit Care Med 1997; 155: 1705-1710.
80. Valentine VG, Taylor DE, Dhillon GS, et al. Success of lung transplantation without surveillance bronchoscopy. J Heart Lung Transplant 2002; 21: 319-326.
81. Brock MV, Borja MC, Ferber L, et al. Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thymocyte globulin, and daclizumab. J Heart Lung Transplant 2001; 20: 1282-1290.
82. Vitulo P, Oggionni T, Cascina A, et al. Efficacy of tacrolimus rescue therapy in refractory acute rejection after lung transplantation. J Heart Lung Transplant 2002; 21: 435-439.
83. Horning NR, Lynch JP, Sundaresan SR, Patterson GA, Trulock EP. Tacrolimus therapy for persistent or recurrent acute rejection after lung transplantation. J Heart Lung Transplant 1998; 17: 761-767.
84. Kahan BD. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group. Lancet 2000; 356: 194-202.
85. Hong JC, Kahan BD. Sirolimus rescue therapy for refractory rejection in renal transplantation. Transplantation 2001; 71: 1579-1784.
86. Snell GI, Levvey BJ, Chin W, et al. A role for sirolimus in lung and heart transplant recipients. Transplant Proc 2001; 33: 1084-1085.
87. Williams JW, Mital D, Chong A, et al. Experiences with leflunomide in solid organ transplantation. Transplantation 2002; 73: 358-366.
88. Chakinala MM, Trulock EP. Acute allograft rejection after lung transplantation: diagnosis and therapy. Chest Surg Clin N Am 2003 (in press).
89. Cooper JD, Billingham M, Egan T, et al. A working formulation for the standarization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant 1993; 12: 713-716.
90. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002; 21: 297-310.
91. Estenne M, Hertz MI. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med 2002; 166: 440-444.
92. Palmer SM, Miralles AP, Howell DN, Brazer SR, Tapson VF, Davis RD. Gastroesophageal reflux as a reversible cause of allograft dysfunction after lung transplantation. Chest 2000; 118: 1214-1217.
93. Lau CL, Palmer SM, Howell DN, et al. Laparoscopic antireflux surgery in the lung transplant population. Surg Endosc 2002; 16: 1674-1678.
94. Davis RD, Lau CL, Eubanks S, Hadjiliadis D, Palmer SM. Improved lung allograft function following fundoplication in lung transplant patients with GERD. J Thorac Cardiovasc Surg 2003; 125: 533-542.
95. Ciccone AM, Stewart KC, Meyers BF, et al. Does donor cause of death affect the outcome of lung transplantation? J Thorac Cardiovasc Surg 2002; 123: 429-434 (discussion 434-436).
96. Hadjiliadis D, Davis RD, Palmer SM. Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients? Chest 2002; 122: 1168-1175.